Literature DB >> 23327034

Dexmedetomidine use in direct laryngoscopic biopsy under TIVA.

Ayse Mizrak1, Maruf Sanli, Semsettin Bozgeyik, Rauf Gul, Suleyman Ganidagli, Elif Baysal, Unsal Oner.   

Abstract

BACKGROUND: The purpose of this study is to investigate the suitability of dexmedetomidine as a helpful sedative agent in direct laryngoscopic biopsy (DLB), under total intravenous anesthesia (TIVA).
METHODS: In this double blind randomised study, patients were allocated to receive dexmedetomidine 0.5 microg/kg (group D, n = 20) or saline placebo (group P, n = 20) intravenously. Forty ASA I-III patients were infused propofol and administered rocuronium bromur. They were intubated and performed biopsy. Aldrete scores, intraoperative propofol and postoperative analgesic requirements, satisfaction scores, recovery time, Ramsay sedation scale (RSS), haemodynamic changes and side effects were recorded.
RESULTS: Postoperative analgesic requirement in group D was significantly lower and satisfaction scores and RSS were significantly higher than in group P. Additionally, MAP (mean arterial blood pressure) significantly decreased at post-extubation time in group D.
CONCLUSION: The premedication with a single dose of dexmedetomidine decreases intraoperative propofol and postoperative analgesic requirements, increases the postoperative satisfaction and RSS considerably in patients undergoing DLB under TIVA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23327034

Source DB:  PubMed          Journal:  Middle East J Anaesthesiol        ISSN: 0544-0440


  3 in total

Review 1.  Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery.

Authors:  Dallas Duncan; Ashwin Sankar; W Scott Beattie; Duminda N Wijeysundera
Journal:  Cochrane Database Syst Rev       Date:  2018-03-06

2.  Dexmedetomidine infusion as an analgesic adjuvant during laparoscopic сholecystectomy: a randomized controlled study.

Authors:  Kateryna Bielka; Iurii Kuchyn; Volodymyr Babych; Kseniia Martycshenko; Oleksii Inozemtsev
Journal:  BMC Anesthesiol       Date:  2018-04-20       Impact factor: 2.217

Review 3.  Dexmedetomidine in perioperative acute pain management: a non-opioid adjuvant analgesic.

Authors:  Chaoliang Tang; Zhongyuan Xia
Journal:  J Pain Res       Date:  2017-08-11       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.